Locations
Copenhagen, Denmark
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Series A
founded in
2016
Hoba Therapeutics is an early-stage biotech company based in Denmark focused on developing innovative treatments for chronic pain disorders and sensorineural hearing loss. The company is working on two novel biopharmaceutical drugs: HB-086, which is in late preclinical development for neuropathic pain, and HB-097, which is in preclinical development for sensorineural hearing loss. Hoba Therapeutics differentiates itself through its unique scientific foundation based on the discovery of neurotrophic factors, meteorin and cometin, which support nerve cell maintenance. With a strong management team and backing from notable investors, Hoba Therapeutics is positioned to address significant unmet medical needs in the healthcare market.
Something looks off?